Clinical Trials Browser

Unknown × Glioma × Temozolomide × Clear all

NCT01107522 2025-09-09

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Phase 1 Unknown

Glioblastoma, Glioma

NCT03243461 2022-06-06

HIT-HGG-2013

Phase 3 Unknown

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neuroepithelial

NCT03932981 2021-09-10

TEMOTRAD01

Phase 2 Unknown

Glioma

NCT03463733 2020-10-08

HUTMZ

Phase 1 Unknown

Glioblastoma, Glioma

NCT04547621 2020-09-14

HSCK-010

Phase 1/2 Unknown

Glioma

NCT04388033 2020-06-09

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Phase 1/2 Unknown

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

NCT00275067 2020-02-25

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Phase 1/2 Unknown

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT03741244 2019-07-23

TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT

Phase 2 Unknown

Glioma

NCT01765088 2018-02-23

A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

Phase 3 Unknown

Astrocytoma, Glioblastoma, Glioma

NCT02416999 2016-02-18

Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas

Phase NA Unknown

Glioma

NCT00083096 2015-02-10

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00516607 2015-02-10

Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01670890 2012-08-22

Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas

Phase 2 Unknown

Glioma

NCT00660283 2010-01-20

KARE003

Phase 2 Unknown

Disease, Glioma

NCT00283543 2007-10-31

Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma

Phase 2 Unknown

Glioma